At the heart of the Oncopole of Toulouse, the CRCT, together with all its partners (institutional, academic, clinical, industrial, charities…), stimulates innovation in terms of research and teaching in the fight against cancer.
The CRCT is a joint Research Unit Inserm & University Toulouse III Paul Sabatier
3 research teams are also labelled by the CNRS
Researchers, clinicians and supports
PhD students and post-doctoral fellows
Overexpression of the oncogenic long noncoding RNA LONA in acute myeloid leukemia and change in its cellular location by the mutant protein NPM1c+.
In this study, we describe the oncogenic role of a novel long noncoding RNA (lncRNA) called LONA (LncRNA Overexpressed in NPM1 mutated Acute myeloid leukemia) overexpressed in patients with acute myeloid leukemia (AML) carrying the mutation of the nucleophosmin NPM1....
A tumour cell experiences mechanical forces of compression, traction and shear. These physical forces induce a signal in the cancer cell. The transmission of this signal is very fast and involves deformation of the cell. A huge current research effort is aimed at...
Radiation therapy must take into account tumor motion. Indeed, during the treatment the target can move up to several centimeters. This could lead to an under dosage of the target or an over dosage of the Organs at Risk (OARs). For classic treamtment the motion is...
Centre de Recherches en Cancérologie de Toulouse
2 avenue Hubert Curien
31037 TOULOUSE CEDEX 1 – FRANCE